BVT.13 is an orally active and selective PPARgamma agonist with a maximal efficacy similar to that of Rosiglitazone (HY-17386). In addition, BVT.13 exhibits antidiabetic activity in ob/ob mice[1].
Molecular Weight:
404.20
Purity:
98.44
CAS Number:
[756813-87-3]
Formula:
C18H11Cl2N3O4
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted